Tuesday, November 14, 2017 5:33:58 AM
Neither have I. And I can't prove any fraud occurred here. Nor can anyone point to any application of the science in humans that has been shown to be successful.
Those are the most basic elements of risk in the investor's equation. As you know most investors can't evaluate the science at all and none completely...you have a better understanding than many, obviously.
The point? Once upon a time there was a company that raised millions of dollars based on the idea that you could sell a boatload of sponges if you put the soap in them FIRST. It was an idea that COULD be executed but the real idea was the selling of shares and people bought them hand over fist. It was as far from a sophisticated concept as one could get.
Here we have, as in all drug development scenarios, an idea that few can grasp or it would have been grasped by other scientists previously. It hasn't been tested in human being #1. And ever since it germinated through some VERY BIG ideas (curing the flu and maybe HIV and scary ebola)….and some smaller ones that I can't pronounce…raising funds as it went, it always came to a stop for some reason. Some good reasons and some unfathomable reasons, at least to the novice investor who can only appreciate putting soap in sponges first.
The point is that a couple of scientists, or a scientist and a couple of shady business operators, could have an idea to create a cure for something knowing full well that the cure couldn't be shown...established beyond any reasonable doubt...to be fatally flawed until it reached the clinical trial stage. Most investors wouldn't be able to discern any flaws in real time.
I don't know whether anything was hatched over 13 years ago. I know that a number of attempts to apply the science have been undertaken by this company and none have been allowed to be tested in a way that would show that they could be shown to be effective. It should raise questions. Frauds in science seem to be hard to prove until its too late for investors. It tends to be more complicated than putting soap in a sponge and the intent of management can be difficult to measure….except by its results over a period of time.
But can it core A apple?
Yes Ralph, of course it can core A apple.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM